PHO91 Antibody

What is PHO91 and why is it significant in research?

PHO91 is a phosphate transporter protein that plays a crucial role in phosphate homeostasis. In organisms like Trypanosoma cruzi (where it is known as TcPho91), this protein localizes to specific cellular compartments such as the contractile vacuole complex (CVC) bladder . The significance of PHO91 lies in its function as a phosphate sodium symporter involved in maintaining appropriate intracellular phosphate levels. Research has demonstrated that alterations in PHO91 expression affect cellular phosphate levels, impacting the concentration of pyrophosphate (PPi) and short-chain polyphosphate (polyP), which are essential for various cellular processes . Understanding PHO91 function provides valuable insights into phosphate metabolism and transport mechanisms across different organisms.

How do I select the appropriate anti-PHO91 antibody for my research?

Selection of an appropriate anti-PHO91 antibody depends on your experimental applications and the specific epitopes you want to target. Consider antibodies raised against conserved regions of the protein if studying PHO91 across different species. For applications like Western blotting (WB) and ELISA, polyclonal antibodies like those generated against specific epitopes may be suitable . When selecting an antibody, evaluate specifications including:

• Host species (rabbit polyclonal antibodies are commonly used)

• Applications the antibody is validated for (WB, ELISA, immunofluorescence)

• Specificity for endogenous levels of the target protein

• Immunogen information (typically synthesized peptides derived from specific regions)

• Purification method (affinity-purification is preferred for increased specificity)

If working with TcPho91 specifically, custom antibodies against specific peptide sequences have been successfully employed in research, as demonstrated in studies using synthetic peptides corresponding to specific amino acid regions (e.g., residues 366-385) .

What are the typical applications for PHO91 antibodies in research?

PHO91 antibodies can be utilized in multiple experimental applications:

• Western blotting (WB): For detecting and quantifying PHO91 expression levels, monitoring changes after genetic manipulations, or comparing expression across different cell types or conditions

• ELISA: For quantitative analysis of PHO91 levels in various samples

• Immunofluorescence assay (IFA): For determining subcellular localization of PHO91, as demonstrated in studies showing its localization to the CVC bladder, plasma membrane, and perinuclear regions under different conditions

• Co-immunoprecipitation: For studying protein-protein interactions involving PHO91

• Immunohistochemistry: For examining tissue distribution patterns

The selection of application should align with your research question—whether you're investigating protein expression, localization, or functional associations of PHO91.

What are the storage and handling recommendations for PHO91 antibodies?

Proper storage and handling of PHO91 antibodies are crucial for maintaining their effectiveness. Based on available information, recommended practices include:

• Storage temperature: Store at -20°C for up to one year to maintain antibody integrity and activity

• Formulation considerations: PHO91 antibodies are typically supplied in liquid form in PBS containing preservatives and stabilizers (e.g., 50% glycerol, 0.5% BSA, and 0.02% sodium azide)

• Freeze-thaw cycles: Minimize repeated freeze-thaw cycles by aliquoting the antibody upon receipt

• Working dilutions: Prepare working dilutions fresh before use and store at 4°C for short periods only

• Contamination prevention: Use sterile techniques when handling antibodies to prevent microbial contamination

Following these storage and handling guidelines will help maintain antibody performance and extend shelf life.

How can I validate the specificity of my PHO91 antibody?

Validation of PHO91 antibody specificity is crucial for reliable research results. Comprehensive validation approaches include:

• Knockdown/knockout controls: Compare signals between wild-type cells and those with reduced PHO91 expression (knockdown) or gene deletion (knockout). Studies have successfully utilized a homologous recombination PCR-based approach to generate knockouts of PHO91 genes, which serve as excellent negative controls for antibody validation

• Overexpression systems: Compare signals between normal cells and those overexpressing PHO91 (e.g., PHO91-GFP fusion proteins)

• Peptide competition assays: Pre-incubate the antibody with the immunizing peptide to demonstrate signal blocking

• Cross-reactivity testing: Test the antibody against related proteins or in non-target species to confirm specificity

• Multiple antibody validation: Use antibodies targeting different epitopes of PHO91 to confirm consistent results

• Western blot analysis for molecular weight confirmation: Verify that the detected band corresponds to the expected molecular weight of PHO91

In published research, antibody specificity has been confirmed through comparative analyses between knockdown parasites (TcPho91-KD) and those overexpressing the protein (TcPho91-OE), demonstrating the utility of genetic manipulation approaches for validation .

What are the best methodological approaches for studying PHO91 localization changes under different experimental conditions?

Investigating PHO91 localization changes requires sophisticated methodological approaches:

• Fluorescent protein tagging: Generate PHO91-GFP fusion constructs for live-cell imaging of dynamic localization changes. This approach has successfully demonstrated translocation of the protein from the CVC to the plasma membrane under phosphate-limited conditions

• Immunofluorescence with specific antibodies: Use anti-PHO91 antibodies with appropriate fluorescent secondary antibodies to visualize native protein localization

• Co-localization studies: Employ organelle-specific markers (e.g., BODIPY-ceramide for endoplasmic reticulum) alongside PHO91 detection to confirm subcellular compartmentalization

• Environmental manipulations: Compare localization patterns under various conditions such as:

  • Normal versus phosphate-restricted growth media

  • Hyposmotic versus hyperosmotic conditions

  • Different developmental stages or cell cycle phases

• Time-course imaging: Capture dynamic changes in localization over time following specific stimuli

• Quantitative image analysis: Develop consistent methods to quantify fluorescence intensity in different cellular compartments

Research has demonstrated that PHO91 can redistribute from its normal localization in the CVC to the plasma membrane when cells are grown in phosphate-deficient media, similar to the behavior observed with other transporters .

How can I design experiments to investigate the functional relationship between PHO91 expression and phosphate homeostasis?

To investigate the functional relationship between PHO91 expression and phosphate homeostasis, consider these experimental approaches:

• Genetic manipulation strategies:

  • Develop knockdown/knockout systems to reduce PHO91 expression

  • Create overexpression systems (e.g., TcPho91-GFP) to increase PHO91 levels

  • Design complementation experiments to restore function in knockdown cells

• Phosphate transport assays:

  • Heterologous expression systems (e.g., Xenopus laevis oocytes) for electrophysiological characterization

  • Radiolabeled phosphate uptake assays to measure transport kinetics

  • Sodium dependency assays to confirm symporter function

• Biochemical measurements:

  • Quantify intracellular phosphate, pyrophosphate (PPi), and polyphosphate (polyP) levels using established assays

  • Compare these levels between wild-type, knockdown, and overexpression systems

• Growth analysis under phosphate limitation:

  • Culture cells in media with varying phosphate concentrations

  • Monitor growth rates to correlate PHO91 expression with survival under limited phosphate conditions

• Osmoregulatory function assessment:

  • Subject cells to hyposmotic and hyperosmotic stress

  • Measure volume changes over time to evaluate the role of PHO91 in osmoregulation

Published research has demonstrated that TcPho91 overexpression leads to increased PPi and short-chain polyP levels, while knockdown results in decreased levels, confirming the protein's role in phosphate homeostasis .

What are the challenges in generating and validating phospho-specific antibodies for PHO91 research?

Generating and validating phospho-specific antibodies for PHO91 research presents several unique challenges:

• Epitope selection considerations:

  • Identifying physiologically relevant phosphorylation sites within PHO91

  • Designing phosphopeptides that maintain appropriate conformation for antibody recognition

  • Addressing potential epitope masking by protein-protein interactions

• Validation strategies for phospho-specific antibodies:

  • Treatment with phosphatases to confirm specificity for phosphorylated forms

  • Comparison of signals before and after stimulation of relevant signaling pathways

  • Mutation of phosphorylation sites to serve as negative controls

  • Mass spectrometry confirmation of phosphorylation sites

• Technical challenges in phospho-antibody generation:

  • Ensuring antibodies recognize only the phosphorylated form and not the unphosphorylated protein

  • Addressing potential cross-reactivity with similar phosphorylated motifs in other proteins

  • Accounting for low abundance of phosphorylated forms in basal conditions

• Application-specific considerations:

  • Optimizing fixation methods to preserve phosphoepitopes for immunofluorescence

  • Incorporating phosphatase inhibitors in sample preparation for Western blotting

  • Determining appropriate stimulation conditions to induce phosphorylation

The regulatory mechanisms of PHO91 through phosphorylation remain an important area for further investigation, particularly regarding how phosphorylation may influence subcellular localization and transport activity.

What are common troubleshooting strategies for weak or non-specific signals when using PHO91 antibodies?

When encountering weak or non-specific signals with PHO91 antibodies, consider these troubleshooting approaches:

• Antibody dilution optimization:

  • Test a range of primary antibody concentrations (typically 1:1,000 to 1:10,000 for Western blotting)

  • Optimize secondary antibody dilutions (typically 1:5,000 to 1:20,000)

• Sample preparation improvements:

  • Ensure complete cell lysis and protein denaturation

  • Include appropriate protease inhibitors to prevent degradation

  • Consider membrane enrichment techniques if PHO91 signal is weak due to low abundance

• Blocking optimization:

  • Test different blocking agents (5% non-fat dry milk, BSA, or commercial blocking buffers)

  • Adjust blocking time and temperature

• Signal enhancement strategies:

  • Use more sensitive detection substrates (enhanced chemiluminescence systems)

  • Increase sample loading amounts for low-abundance proteins

  • Consider signal amplification methods for immunofluorescence applications

• Background reduction:

  • Increase washing duration and frequency (typically five washes with PBS-T)

  • Optimize incubation time and temperature

  • Pre-absorb antibodies if non-specific binding is an issue

• Alternative detection methods:

  • If Western blotting yields poor results, try immunoprecipitation followed by Western blotting

  • Consider switching between polyclonal and monoclonal antibodies based on your application

Successful detection of PHO91 has been achieved using affinity-purified antibodies at dilutions of 1:5,000 with appropriate washing protocols (five times with PBS-T) and secondary antibody dilutions of 1:20,000 .

How can I optimize protein extraction protocols specifically for PHO91 detection?

Optimizing protein extraction for PHO91 detection requires consideration of its membrane localization and biochemical properties:

• Membrane protein extraction considerations:

  • Use detergent-based lysis buffers (e.g., modified RIPA buffer containing 150 mM NaCl, 20 mM Tris-Cl pH 7.5, 1 mM EDTA, 1% SDS, and 0.1% Triton X-100)

  • Consider sequential extraction methods to separate different membrane fractions

  • Include glycerol (e.g., 50%) in extraction buffers to stabilize membrane proteins

• Subcellular fractionation approaches:

  • Develop protocols to isolate specific cellular compartments where PHO91 localizes

  • For contractile vacuole complex isolation, use density gradient centrifugation

  • For plasma membrane isolation, consider two-phase partitioning techniques

• Protease inhibition strategy:

  • Include a comprehensive protease inhibitor cocktail in all extraction buffers

  • Use freshly prepared buffers to ensure inhibitor activity

  • Consider adding specific inhibitors based on the model organism's proteases

• Sample processing considerations:

  • Maintain samples at 4°C throughout processing

  • Optimize centrifugation steps: low-speed centrifugation (1,000 × g) to remove debris followed by high-speed centrifugation (50,000 × g) to collect membrane fractions

  • Avoid excessive sonication or vortexing that might disrupt protein complexes

• Sample storage:

  • Aliquot samples to avoid repeated freeze-thaw cycles

  • Store at -80°C for long-term preservation of protein integrity

Successful protocols have utilized differential centrifugation followed by resuspension in detergent-containing buffers for effective extraction of membrane-associated PHO91 .

What experimental controls should be incorporated when studying PHO91 function through antibody-based techniques?

Rigorous experimental controls are essential when studying PHO91 function using antibody-based techniques:

• Expression controls:

  • Positive control: Samples with confirmed PHO91 expression (e.g., overexpression systems)

  • Negative control: Samples with knockdown or knockout of PHO91 gene

  • Loading control: Antibodies against housekeeping proteins (e.g., α-tubulin at 1:40,000 dilution)

• Antibody specificity controls:

  • Primary antibody omission: To assess secondary antibody non-specific binding

  • Isotype control: Using matched isotype antibody to evaluate non-specific binding

  • Peptide competition: Pre-incubation with immunizing peptide to verify specific binding

• Functional assay controls:

  • Wild-type cells alongside genetically modified lines in all functional assays

  • Time-course sampling to establish temporal relationships

  • Parallel assessment of related transporters to evaluate specificity of effects

• Localization controls:

  • Co-localization with established organelle markers

  • Fractionation purity controls when isolating subcellular compartments

  • Negative controls using antibodies against proteins known not to localize with PHO91

• Environmental manipulation controls:

  • Media composition controls when testing phosphate-limitation responses

  • Osmolarity controls when assessing osmoregulatory function

  • Time-matched controls for stress-response experiments

Research has effectively employed these controls, particularly comparing wild-type, TcPho91-KD, and TcPho91-OE parasites in multiple functional assays to establish the specific effects of PHO91 expression levels .

How should I interpret contradictory results between different antibody-based detection methods for PHO91?

When faced with contradictory results between different antibody-based detection methods for PHO91, consider this systematic approach to resolution:

• Method-specific limitations assessment:

  • Western blotting: Evaluates denatured proteins and may miss conformational epitopes

  • Immunofluorescence: Preserves spatial information but may involve epitope masking

  • ELISA: Provides quantitative data but may be affected by sample matrix effects

  • Flow cytometry: Offers single-cell resolution but may be affected by fixation methods

• Antibody characteristic analysis:

  • Epitope location: Different antibodies may recognize distinct regions of PHO91

  • Clonality differences: Monoclonal vs. polyclonal antibodies have different recognition properties

  • Sensitivity variations: Detection thresholds may differ between antibodies and methods

• Biological context interpretation:

  • Differential protein processing in various compartments

  • Post-translational modifications affecting epitope accessibility

  • Protein-protein interactions masking certain epitopes in specific contexts

• Validation through complementary approaches:

  • Genetic validation: Confirm phenotypes with knockout/knockdown systems

  • Functional assays: Correlate contradictory detection results with functional outcomes

  • Mass spectrometry: Use antibody-independent methods to verify protein presence and modifications

• Reconciliation strategies:

  • Generate new antibodies against different epitopes

  • Optimize each method independently with appropriate controls

  • Consider that contradictions may reflect actual biological complexity rather than technical artifacts

Researchers have successfully navigated such challenges by employing multiple detection methods and correlating results with functional assays, such as measurements of phosphate-related metabolites (PPi and polyP) and growth characteristics .

How can PHO91 antibodies be utilized to study stress-induced protein relocalization?

PHO91 antibodies can be powerful tools for investigating stress-induced protein relocalization through these methodological approaches:

• Comparative immunolocalization under various stress conditions:

  • Phosphate limitation: Compare localization in normal media versus phosphate-restricted conditions

  • Osmotic stress: Examine localization changes during hyposmotic and hyperosmotic challenges

  • Other environmental stressors: pH changes, oxidative stress, or nutrient deprivation

• Live-cell imaging approaches:

  • Use GFP-tagged PHO91 constructs for real-time visualization of dynamic relocalization

  • Employ photoactivatable or photoconvertible fusion proteins to track specific protein populations

  • Implement FRAP (Fluorescence Recovery After Photobleaching) to measure mobility between compartments

• Quantitative co-localization analysis:

  • Calculate Pearson's or Mander's coefficients to measure degree of co-localization with compartment markers

  • Develop custom image analysis pipelines to quantify protein distribution across cellular compartments

  • Perform time-course analyses to determine the kinetics of relocalization events

• Correlative microscopy approaches:

  • Combine immunofluorescence with electron microscopy for ultrastructural localization

  • Implement super-resolution microscopy techniques for detailed spatial information

• Mechanistic investigations:

  • Use cytoskeleton disrupting agents to test dependencies on trafficking machinery

  • Employ temperature blocks to arrest vesicular transport at specific stages

  • Apply protein synthesis inhibitors to distinguish new synthesis from redistribution

Research has demonstrated that PHO91 relocalization from the contractile vacuole complex to the plasma membrane occurs under phosphate-limited conditions, suggesting an adaptive response mechanism similar to that observed with other transporters .

What are the key differences in experimental outcomes between PHO91 knockdown and overexpression models?

Experimental studies comparing PHO91 knockdown and overexpression models have revealed significant functional differences:

These contrasting phenotypes demonstrate the essential role of PHO91 in phosphate homeostasis, growth under phosphate limitation, and osmoregulation, providing valuable insights into the functional significance of this transporter .

How do different experimental conditions affect the sensitivity and specificity of PHO91 antibody detection?

Various experimental conditions can significantly impact PHO91 antibody detection parameters:

These parameters should be systematically optimized for each specific application and antibody to achieve reliable detection of PHO91 under different experimental conditions.